Menu
/REGISTER
Montecito
FMB
Loading...
You are here:  Home  >  Biotech  -  Page 10

Santa Barbara Web Design
Latest

Lawsuit financing evens scales on patent protection

By   /  Friday, October 4th, 2019  /  Biotech, East Ventura County, Law, Small Business, South Coast, Startups, Technology, Top Stories, Top Story  /  Comments Off on Lawsuit financing evens scales on patent protection

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Tri-county biotech upstarts struggle to maintain stock prices

By   /  Friday, October 4th, 2019  /  Biotech, East Ventura County, right, Tri-County Public Companies  /  Comments Off on Tri-county biotech upstarts struggle to maintain stock prices

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Sienna Biopharmaceuticals filing for Chapter 11 bankruptcy

By   /  Tuesday, September 17th, 2019  /  Biotech, Earnings, East Ventura County, Health Care, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Sienna Biopharmaceuticals filing for Chapter 11 bankruptcy

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen trades cash for cash flow with Otezla deal

By   /  Friday, August 30th, 2019  /  Biotech, East Ventura County, Health Care, Top Stories, Top Story, Tri-County Public Companies  /  Comments Off on Amgen trades cash for cash flow with Otezla deal

Amgen’s $13.4 billion acquisition of lucrative psoriasis therapy Otezla secures nearly a decade of revenue growth for the biotech giant to bridge the gap between its waning legacy products and potential new contenders. The relatively small deal could nonetheless change the landscape of the biotech industry, allowing regulators to approve a $74 billion takeover bid Read More →

Read More →
Latest

Dubroff: 5 reasons to pay attention to Amgen’s Otezla deal

By   /  Friday, August 30th, 2019  /  Biotech, Columns, Latest news  /  Comments Off on Dubroff: 5 reasons to pay attention to Amgen’s Otezla deal

Henry Dubroff

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Judge overturns verdict upholding Repatha patents

By   /  Thursday, August 29th, 2019  /  Biotech, East Ventura County, Latest news, Law  /  Comments Off on Judge overturns verdict upholding Repatha patents

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen’s stock climbs after announcing Otezla acquisition

By   /  Monday, August 26th, 2019  /  Biotech, East Ventura County, Latest news, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen’s stock climbs after announcing Otezla acquisition

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →